Cancer Center of Central Conn.

Southington, Connecticut 06489

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia

Studies at this site

• An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia — Completed